|
Barbara McGovern, M.D.
After earning her medical degree at Albert Einstein College of Medicine in 1988, Dr. McGovern completed her residency and fellowship training in Infectious Diseases at New England Medical Center. Her interest in HIV/hepatitis C coinfection grew out of her clinical work in the only women's prison in Massachusetts, where she began to observe a marked increase in the number of liver-related deaths among her HIV-positive patients. In response to these findings, Dr. McGovern established an HIV/hepatitis C coinfection clinic in January 2000 geared specifically toward community and incarcerated patients. As clinical director of this clinic, she trains infectious disease fellows in the evaluation and management of people who are coinfected with HIV and hepatitis C. Dr. McGovern's research on viral hepatitis and hepatic steatosis has appeared in many journals, including Clinical Infectious Diseases, AIDS and the Journal of Acquired Immune Deficiency Syndromes. She has frequently presented at major HIV and liver conferences and was on the United States Public Health Service task force to develop treatment guidelines for HIV/Hepatitis B coinfected patients. She has also authored a chapter on HIV/hepatitis C and HIV/hepatitis B coinfection in UpToDate, a highly regarded clinical resource used by physicians worldwide. Disclosures Dr. McGovern has been a consultant for Roche Laboratories. |